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Introduction: Tumefactive fibroinflammatory lesion is an idiopathic fibrosclerosing disorder occurring in the head
and neck region. It is one of a broad spectrum of entities named inflammatory pseudotumors and, as the name
suggests, it mimics a lot of diseases such as malignancies or infections. Combined with its rarity, tumefactive
fibroinflammatory lesion can be a tremendous diagnostic challenge. This case report describes a case of
tumefactive fibroinflammatory lesion, which was initially thought to be peri-orbital and mandibular osteomyelitis
caused by Aspergillus. A lengthy work up ensued and was required to reach the final diagnosis.
Case presentation: A 64-year-old Asian man with a history of diabetes mellitus and chronic kidney disease who
was on hemodialysis presented with worsening exophthalmos and relapsing trismus. He was diagnosed as
“mandibular osteomyelitis” about 20 years ago. Since then he had suffered chronic relapsing exophthalmos and jaw
pain with numerous medical treatments. In 2011 he was diagnosed as peri-orbital and intramandibular aspergillosis
because a serum Aspergillus galactomannan assay was positive. He was treated with multiple antifungal medications to
no avail. A biopsy of his orbital lesions was not revealing. After repeated biopsies, we finally concluded that the patient
was suffering from tumefactive fibroinflammatory lesion. Corticosteroid therapy was initiated with prompt response.
Conclusions: Tumefactive fibroinflammatory lesion is a rare inflammatory benign tumor, which mimics many
inflammatory and neoplastic disorders. Conventional work up including biopsy may not lead to the diagnosis without
understanding this entity. Awareness of this disorder will aid early diagnosis and treatment.
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Tumefactive fibroinflammatory lesion (TFIL) is a rare
idiopathic fibrosclerosing disorder occurring in the head
and neck region, with a benign histological appearance
[1]. It is one of a broad spectrum of entities called in-
flammatory pseudotumors [2]. Rice et al. first described
the abnormality in 1975 and named this as sclerosing
cervicitis [3]. Histologically identical lesions were subse-
quently reported involving parotid gland, nasal and para-
nasal sinuses, maxillary antrum, infratemporal fossa, lung,
and extremities [4-7]. This lesion clinically simulates a
malignant neoplasm without metastasis, but is histologically
benign. Its histopathologic appearance is nearly identical to* Correspondence: kiwata@med.kobe-u.ac.jp
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reproduction in any medium, provided the orthat of fibrosclerotic lesions of the mediastinum and ret-
roperitoneum, as well as of Riedel’s thyroiditis [4]. The
etiology of TFIL is unknown. In this case report we de-
scribe a case of TFIL in a Japanese man whose condition
remained undiagnosed for about 20 years.
Case presentation
A 64-year-old Asian man was referred to the Division of
Infectious Diseases with a past medical history of trismus,
exophthalmos, and positive serum Aspergillus galacto-
mannan assay. His past medical history included diabetes
mellitus type 2 for 25 years and chronic kidney disease on
hemodialysis for 10 years.
About 20 years prior to the current presentation, he was
diagnosed with “mandibular osteomyelitis” and treated with
unknown antibiotics. About 10 years prior to the presenta-
tion, he was reported to have suffered candidemia. At thatLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kusaka et al. Journal of Medical Case Reports 2013, 7:260 Page 2 of 5
http://www.jmedicalcasereports.com/content/7/1/260time, a radioisotope bone scan showed an uptake in his
mandibular and he was treated with unknown antibi-
otics. His symptoms of “mandibular osteomyelitis” had
waxed and waned since then. About 8 years prior to the
presentation, another recurrence of “mandibular osteo-
myelitis” occurred and multiple antibiotics were provided
including clarithromycin, levofloxacin, minocycline and
fluconazole.
About 2 years prior to the current presentation, swelling
of his left eyelid developed and it spread to his cheek. A
computed tomography (CT) scan of the area revealed a
lesion consistent with inflammation around his mandibu-
lar joint and surrounding soft tissue. Left exophthalmos
with pain developed 2 months later. Magnetic resonance
imaging of the area found an intra-orbital mass-like lesion
and a lesion consistent with inflammation around his left
masseter muscle. His visual acuity was slightly declining
(from 20/30 to 20/100). Most symptoms improved to
some extent without specific treatment but his visual
acuity remained unchanged.
Bilateral mandibular pain developed 2 months prior
to the current presentation (September 2011). Levofloxa-
cin was provided without improvement. On the following
month, an ophthalmological examination revealed swell-
ing of his left eyelid, exophthalmos, and impaired visual
acuity (from 20/100 to 20/220). He was referred and
admitted to the Division of Infectious Diseases service
because of an elevated Aspergillus galactomannan level (0.5
optical density (OD) index; reference normal level <0.5 OD
index) in December 2011.
On admission, he was alert and his vital signs were:
temperature 36.7, pulse rate 79/minute regular, blood pres-
sure 143/63mmHg, and respiratory rate 12/minute. He
had trismus and was able to open his mouth only by a
few centimeters. There was no muscle spasm or fascicu-
lation. His left eyelid was swollen with exophthalmos.
The light reflex of his left eye was slow and weak. Supra-
duction of his left eye was impaired. There were no tender
to touch areas on his face. His left vision was 20/220. The
rest of his physical examination was unremarkable. A
blood test revealed elevated Aspergillus galactomannan
level (0.5 OD index), C-reactive protein level (8.6mg/dL)
and erythrocyte sedimentation rate (86mm/hour) but
was otherwise unremarkable, including a β-D-glucan assay
which was <3pg/mL (reference range <20.0pg/mL). Im-
aging studies demonstrated no evidence of pancreatitis,
mediastinal or retroperitoneal fibrosis, Riedel’s thyroid-
itis or Mikulicz’s disease.
Intravenous liposomal amphotericin B (300mg/day
or 5mg/kg/day) and oral voriconazole (400mg/day) com-
bination was initiated for presumptive chronic osteomye-
litis caused by Aspergillus. In addition, dexamethasone
(6mg/day) was provided to try to reduce inflammation
to protect his vision. However, his visual acuity continuedto decline and exophthalmos worsened gradually. On
the 4th day after the admission, a surgical debridement
was performed to decompress the optic canal and the
orbit. Upon surgery, his extra-ocular muscles and eye-
ball were almost intact. However, there was thickening
of the periostea of the bones surrounding his orbit up to
7mm. The lesion appeared inflamed and had a greenish
yellow color on visual inspection. The staining and cul-
ture of debrided specimens were negative for bacteria,
mycobacteria, and fungi. At histology, mildly atrophic
lachrymal glands and ducts were surrounded by sclerotic
fibrous stroma. Fibrosis was arranged in a concentric pat-
tern around the ducts (periductal fibrosis). Although there
were several foci of lymphocytic aggregation at the per-
iphery of the lobules of his lachrymal glands, plasma
cells or eosinophils were not dominant and only a few
immunoglobulin (Ig) G4-positive cells were identified
immunohistochemically. Typical obliterative phlebitis was
not seen (Figure 1). The patient’s visual acuity, trismus,
and exophthalmos partially improved after the operation.
He was discharged home 15 days after the admission.
Voriconazole was continued without corticosteroids.
Two months after the admission, exophthalmos and
trismus on the right (opposite) side developed, accom-
panied by profound fatigue and appetite loss. He was re-
admitted to the hospital. His Aspergillus galactomannan
level was 0.3 OD index. Liposomal amphotericin B was
restarted and voriconazole was continued. However, he
had exophthalmos, his visual acuity declined and his head-
ache worsened. Dexamethasone was restarted (6mg/day)
on the day of admission to rescue his visual acuity.
Another operation for decompression was performed
10 days after the second admission, and this time, speci-
mens were not sent for pathological examination due to
a communication error. His symptoms improved since
the operation. Dexamethasone was tapered off after 4
weeks. He was again discharged home on oral voriconazole.
A month after the second discharge (April 2012), how-
ever, another episode of trismus occurred. He was again
hospitalized on May 1, 2012. He was not able to open
his mouth at all because of trismus. There was severe
tenderness on his bilateral orbits, maxilla and mandible.
There were also lymphadenopathies on the left side of
his neck with diameters up to 15mm.
A CT scan of the lesion showed findings consistent with
osteosclerotic change on mandible, orbits and skull base,
mucous thickening of maxillary sinus, and masseter
muscle swelling with calcification (Figure 2).
His blood test was noted for elevated alkaline phosphat-
ase level (1164mg/dL) and C-reactive protein (14.0mg/dL).
His serum IgG4 level was within normal range (10.4mg/dL).
Liposomal amphotericin B was added to voriconazole
again, but his symptoms continued to worsen. He became




Figure 1 Histology of the lachrymal gland and mandibular bone. Fibrous inflammation characteristic of tumefactive fibroinflammatory lesion.
(a) Hematoxylin and eosin staining of mandibular bone. Trabeculae were lined by osteoblasts showing active bone remodeling, and intertrabecular spaces
were filled with fine fibrous tissue. There was mild lymphocytic infiltration, but no evidence of active osteomyelitis. (b) (c) (d) Hematoxylin and
eosin staining of lachrymal gland. (b) Lachrymal glands and ducts were surrounded by sclerotic fibrous stroma (arrow). (c) The lobules are slightly atrophic.
Periductal sclerotic fibrosis (arrow) was seen. (d) Lymphocytic aggregate was seen at the periphery of the lobule. (e) (f) Immunohistochemical staining for
IgG (e) and IgG4 (f) of lachrymal gland. IgG4-positive cells (arrow) were very few.
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systemic condition, empiric steroid therapy (prednisolone
40mg/day) was started to control the severe systematic
inflammation. Five days after starting the steroid, biopsy
was performed under general anesthesia on day 30 after
the admission, and samples were taken from every site
where pain or inflammation was observed (mandibular
bone, maxillary sinus mucous, masseter muscle and cer-
vical lymph nodes). In the biopsy specimens of maxillary
and mandibular bones, trabeculae were lined by osteo-
blasts showing active bone remodeling, and intertrabe-
cular spaces were filled by fine fibrous tissue with mildlymphocytic infiltration. Around the facial artery, there
was dense fibrosis of which the histological findings
were similar to those of the previous operation. Nasal
mucosa was edematous and mild lymphocytic and plas-
macytic infiltration was seen. Immunohistochemistry for
IgG4 was performed in bone, soft tissue around the facial
artery, and nasal mucosa, and positive cells were very few
in every specimen (Figure 1).
After a lengthy time-course, the nature of recurring
chronic inflammation at head and neck, unresponsive-
ness to antifungal medication and fibrotic inflammatory
pathologic findings, we finally concluded that the diagnosis
Figure 2 Computed tomography scan of the facial lesion about 1 month after the admission. Computed tomography shows findings
consistent with (a) diffuse osteosclerotic change on orbits and skull base and peri-orbit soft tissue swelling, (b) mucous thickening of maxillary
sinus and marked swelling of masseter.
Kusaka et al. Journal of Medical Case Reports 2013, 7:260 Page 4 of 5
http://www.jmedicalcasereports.com/content/7/1/260was TFIL. His symptoms resolved within a week and the
patient was discharged home on oral steroid mainten-
ance therapy.
Discussion
This case report presents a case of TFIL, which remained
undiagnosed for about 20 years. Exophthalmos and tris-
mus were probably caused by the effect of inflammation
of mandibular bone and orbital bones. The patient had
been treated for “chronic osteomyelitis” repeatedly to no
avail. We hypothesized initially that he had been suffering
from chronic osteomyelitis caused by Aspergillus, since
he was assumed to be immunocompromised by having
diabetes mellitus, and a galactomannan assay was posi-
tive. Galactomannan assay is sensitive and specific in
diagnosing invasive aspergillosis (79 to 96%, 74 to 99%
respectively), but the role of this assay in chronic Aspergillus
infection is not well established [8]. Galactomannan assay
is also known to cause false-positive results, particularly in
patients who receive penicillins or other fungal infections.
A false-positive result may also occur without any known
causes [8]. We continued antifungal medications since
chronic Aspergillus infection may not respond well to the
antifungal medications. However, the recurring nature
of longstanding illness, failure to identify the causative
organisms by repeated cultures and histological exami-
nations, and multiple site osteomyelitis (peri-orbital and
mandible) were not very consistent with this diagnosis.
Because of the chronic inflammatory nature, we also
considered diagnoses such as tuberculosis; sarcoidosis;
varieties of vasculitis; relapsing polychondritis; SAPHO
(synovitis, acne, pustulosis, hyperostosis and osteitis)syndrome; histiocytosis X; and Erdheim–Chester disease
[9], but clinical presentation and histological findings
were not consistent with these disorders.
The diagnosis of TFIL is mainly based on clinical fea-
tures and histological examinations. Clinical pictures of
TFIL include lesions spreading to almost all areas of
head and neck, sometimes (approximately 20%) accom-
panied by retroperitoneal or mediastinum fibrosclerotic
lesion, orbital pseudotumor or Riedel’s thyroiditis. Macro-
scopically, these lesions are firm and tannish-white to
gray-white and sometimes show a locally invasive nature
like malignancy.
At histology, they appear benign and composed of
mature fibrous tissue sparsely interspersed with normal-
appearing fibroblasts, lymphocytes, and a few poly-
morphonuclear cells [10]. The lesions frequently extend
into adjacent soft tissue and may encase blood vessels,
nerves, and ducts.
In our case, the clinical picture and the macroscopic
and microscopic features were consistent with these diag-
nostic criteria, and we finally made the diagnosis of TFIL.
Recent literature suggests several inflammatory diseases
including TFIL may be a variation of IgG4-related disease
[11]. IgG4-related disease is relatively common in Japan
and thousands of patients may develop this disorder
annually [12]. Elevated concentrations of IgG4 in serum
and massive infiltration of IgG4+ plasma cells in the
lesion are characteristic of IgG4-related disease and
are helpful in diagnosing it [11,13]. Unfortunately, these
markers are not specific diagnostic markers and specific
pathological findings are more essential for diagnosis
than negative marker findings [11]. In our case, serological
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ings suggesting IgG4-related disease were seen (such as
dense lymphoplasmacytic infiltrate, obliterative phlebitis
or eosinophil infiltrate). Therefore, we do not consider
that our case was one variation of IgG4-related diseases.
Very few cases of TFIL have been reported in Japan
[14], but it is possible that TFIL is more common than
thought and cases may have been categorized as one
variation of IgG4-related disease, or may have remained
undiagnosed.
Idiopathic orbital inflammation is another disorder, which
appeared similar to the current case, and it may also be
associated with IgG4-related disease [15]. The presence
of a mandibular lesion in our case is, however, not con-
sistent with this disorder.
Treatment of TFIL remains controversial. A cortico-
steroid, such as prednisolone 0.6 to 1.0mg/kg/day taper-
ing for several months, is effective to some extent. If the
patient is suffering from compression symptoms, surgical
intervention is needed. In some cases, radiation therapy
is added to medical or surgical therapy [1]. Despite the
benign nature of this lesion, recurrence and disease per-
sistence are common. These patients require long-term
follow-up and also may require corticosteroids mainten-
ance therapy for months to years.
In our case, the patient did not respond well to the
steroid therapies provided twice before. This may have
reflected the rather short duration of the treatment, but
also may have reflected the rather unpredictable nature
of clinical response to the treatment in TFIL.
Better understanding of the pathophysiology of TFIL,
particularly in relation to IgG4-related disease, should be
elucidated by further studies.
Conclusions
TFIL can be a considerable diagnostic challenge. Years
of diagnostic work up and management were needed for
reaching a conclusive diagnosis of TFIL in our case.
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